Core Insights - DENTSPLY SIRONA Inc. reported a mixed performance for Q4 2025, with adjusted EPS of 27 cents, a 3.8% increase year over year, but missing the Zacks Consensus Estimate by 3.6% [1] - The company experienced a revenue growth of 6.2% year over year, totaling $961 million in the fourth quarter, surpassing estimates by 4.5% [2] - A restructuring plan was announced, aiming for $120 million in annualized cost savings, with a focus on debt reduction and reinvestment in growth initiatives [16][17] Financial Performance - Adjusted EPS for the full year 2025 was $1.60, down 4.6% year over year, while GAAP loss per share was $3.00 compared to $4.48 in the previous year [1] - Total sales for 2025 were reported at $3.68 billion, a decrease of 3% year over year [2] Segment Analysis - Revenues from the Connected Technology Solutions segment were $299 million, reflecting a 1.8% increase but a 1.9% decrease year over year [3] - Essential Dental Solutions segment revenues reached $372 million, up 7.8% year over year [4] - Orthodontic and Implant Solutions segment revenues were $202 million, up 9.8% year over year [4] - Wellspect Healthcare segment revenues totaled $88 million, up 6.9% year over year [5] Geographic Performance - U.S. revenues increased by 14.5% year over year [6] - European revenues rose by 4.8% year over year, but declined by 2.9% at constant currency [6] - Revenues from the Rest of World declined by 0.6% year over year [7] Margin Analysis - Adjusted gross profit improved by 0.4% year over year to $479 million, but the adjusted gross margin contracted by 300 basis points to 49.8% [10] - Adjusted operating profit decreased by 10.4% year over year to $86 million, with an adjusted operating margin of 13.2% [11] Financial Position - The company ended Q4 2025 with cash and cash equivalents of $363 million, unchanged from the previous quarter, and total debt decreased to $2.33 billion [12] - Cumulative net cash from operating activities was $235 million, down from $461 million in the prior year [12] Future Outlook - DENTSPLY SIRONA expects 2026 sales to be between $3.5 billion and $3.6 billion, with adjusted EPS projected in the range of $1.40 to $1.50 [14] - The Zacks Consensus Estimate for 2026 sales is currently $3.67 billion, and for adjusted EPS, it is $1.49 [14] Market Reaction - Shares of DENTSPLY SIRONA rose nearly 7.8% in pre-market trading despite the earnings miss, reflecting investor optimism regarding the restructuring and capital deployment strategy [9][17]